QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

HROW

QT74Harrow Health, Inc.
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·USA
Latest market price
42.87
+0.93+2.22%
OverviewShort InterestFilings
HROWQT74Harrow Health, Inc.·NASDAQ
OverviewShort InterestFilings
42.87+2.22%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01LNTH+0.65%$103.86
Snapshot
Index-P/E-EPS (ttm)
-0.40
Insider Own-
Shs Outstand37.28M
Perf Week13.86%
Market Cap1.56BForward P/E18.59EPS next Y2.31Insider Trans-0.56%Shs Float-Perf Month39.73%
Enterprise Value1.77BPEG0.46EPS next Q-0.23Inst Own-Short Float-Perf Quarter24.59%
Income-15007853.00P/S5.82EPS this Y161.88%Inst Trans-Short Ratio-Perf Half Y-4.24%
Sales268.68MP/B54.40EPS next Y831.82%ROA-3.57%Short Interest-Perf YTD-12.51%
Book/sh0.75P/C102.70EPS next 5Y140.28%ROE-33.65%52W High54.85 -21.84%Perf Year40.97%
Cash/sh2.55P/FCF109.49EPS past 3/5Y-ROIC8.55%52W Low28.54 50.21%Perf 3Y-
Dividend Est.-EV/EBITDA56.23Sales past 3/5Y45.12% 40.89%Gross Margin74.11%Volatility3.81% 3.72%Perf 5Y-
Dividend TTM-EV/Sales6.59EPS Y/Y TTM140.82%Oper. Margin10.47%ATR (14)2.14Perf 10Y-
Dividend Ex-Date-Quick Ratio2.30Sales Y/Y TTM34.50%Profit Margin-5.57%RSI (14)71.68Recom2.00
Dividend Gr. 3/5Y-Current Ratio2.48EPS Q/Q-65.79%SMA2020.22%Beta1.76Target Price73.67
Payout0.00%Debt/Eq10.47Sales Q/Q-8.33%SMA5016.93%Rel Volume1.33Prev Close41.94
Employees382LT Debt/Eq4.83EarningsAug 10SMA2004.08%Avg Volume806.50KPrice42.87
IPO DateSep 28, 2007Option/ShortYes / YesEPS/Sales Surpr.-46.51% -15.38%Net Debt/EBITDA6.55Volume1,070,783Change2.22%
Analyst Ratings
DateActionAnalystRatingTarget
May-13-26ReiteratedCantor FitzgeraldOverweight$94 → $88
Mar-18-26ReiteratedBTIGBuy$63
Mar-04-26ReiteratedH.C. Wainwright$64 → $70
Nov-11-25ReiteratedCantor Fitzgerald$76 → $94
Sep-29-25ReiteratedLake StreetBuy$55 → $70
Sep-23-25ReiteratedCraig-HallumBuy$45 → $64
Aug-13-25ReiteratedH.C. Wainwright$60 → $64
Jul-11-25InitiatedCantor Fitzgerald amid path to growthOverweight$76
Oct-18-24ReiteratedB.Riley Financial$73
Oct-04-24ReiteratedLake StreetBuy$25 → $55
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue269272200
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A696849
Gross Profit200204150
Selling, General and Administrative Excl. Other861530
Research and Development151312
Other Operating Expense700130
Operating Income28399
Interest Expense222423
Unusual Expense
———
Non-Operating Income (Expense)16160
Net Income Before Taxes-12-2-17
Income Taxes430
Consolidated Net Income-15-5-17
Net Income From Continuing Operations-15-5-17
Net Income-15-5-17
EPS (Recurring)-0.39-0.14-0.49
EPS (Basic, Before Extraordinaries)-0.39-0.14-0.49
EPS (Diluted)-0.40-0.14-0.49
EBITDA324122
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio5.906.67—
Gross Margin74.3575.0075.00
Operating Margin10.4114.344.50
Net Margin-5.58-1.84-8.50
Shares Outstanding373736
Market Capitalization1,5861,813—
Operating Lease Expense
———
Insider Trading Volume
$48.65$45.42$42.20$38.98$35.75● Close Price0.00M1.96M3.92M5.88M7.85MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Graves Adrienne LDirectorMay 18 '26Buy31.071,00031,0701,000May 19 12:00 AM
SILVERNAIL LAUREN PDirectorMay 18 '26Buy31.001,00031,0001,000May 19 12:00 AM
BAUM MARK LCHIEF EXECUTIVE OFFICERMay 14 '26Buy30.2010,000302,0002,996,130May 15 12:00 AM
BOLL ANDREW R.PRESIDENT AND CFOMay 14 '26Buy29.903,500104,650814,679May 15 12:00 AM
Opaleye Management Inc.10% OwnerMar 04 '26Sale39.67138,2635,485,18359,428Mar 05 12:00 AM
Opaleye Management Inc.10% OwnerMar 03 '26Sale39.1560,3092,361,24263,691Mar 05 12:00 AM
Opaleye Management Inc.10% OwnerFeb 27 '26Sale54.185,000270,90065,000Mar 03 12:00 AM
Opaleye Management Inc.10% OwnerJan 06 '26Sale53.3520,0001,066,91470,000Jan 08 12:00 AM
BOLL ANDREW R.PRESIDENT AND CFODec 12 '25Option Exercise3.95120,000474,000837,844Dec 16 12:00 AM
BAUM MARK LCHIEF EXECUTIVE OFFICERDec 12 '25Option Exercise3.95360,0001,422,0003,066,124Dec 16 12:00 AM
BAUM MARK LCHIEF EXECUTIVE OFFICERJul 21 '25Option Exercise7.87600,0004,722,0003,199,462Jul 23 12:00 AM
BAUM MARK LCHIEF EXECUTIVE OFFICERJul 31 '15Option Exercise7.87600,0004,722,0000Jul 23 12:00 AM
Opaleye Management Inc.10% OwnerJun 10 '25Sale30.8015,000462,03390,000Jun 11 12:00 AM
Opaleye Management Inc.10% OwnerJun 09 '25Sale30.3715,204461,794105,000Jun 11 12:00 AM
Opaleye Management Inc.10% OwnerJun 04 '25Sale30.021,79653,907120,204Jun 05 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR